How many employees does Arvinas, Inc. have?

Arvinas, Inc. reported 246 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 24, 2026. That is down 42.8% from a year earlier.

What is Arvinas, Inc.'s revenue per employee?

Arvinas, Inc. brought in $263M of revenue in fiscal Dec 2025, which is $1.07M per employee. That ranks 31 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Arvinas, Inc. employees and revenue per employee

ARVN · Biotechnology · $493M market cap

Arvinas, Inc. had 246 employees at the end of fiscal Dec 2025, down 42.8% from a year earlier. Revenue for the year was $263M, down 0.3% from a year earlier, or $1.07M per employee. Revenue fell, and headcount fell or held flat with it.

Employees

246

-42.8% YoY

Revenue

$263M

-0.3% YoY

Revenue / employee

$1.07M

Peer median $459K

Rank in industry

31 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2018

Hover a year for the numbers.

ARVN employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	246	$263M	$1.07M	-42.8%	-0.3%
Dec 2024	430	$263M	$613K	-3.4%	+235.5%
Dec 2023	445	$78.5M	$176K	+7.2%	-40.3%
Dec 2022	415	$131M	$317K	+48.2%	+145.1%
Dec 2021	280	$53.6M	$191K	+56.4%	+106.9%
Dec 2020	179	$25.9M	$145K	+34.6%	-39.7%
Dec 2019	133	$43.0M	$323K	+60.2%	+200.0%
Dec 2018	83	$14.3M	$173K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Arvinas, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
LGND Ligand Pharmaceuticals Incorporated	47	$268M	$5.70M	Leaner
ANAB AnaptysBio, Inc.	104	$235M	$2.26M	Leaner
RIGL Rigel Pharmaceuticals, Inc.	172	$294M	$1.71M	Efficient growth
ARVN Arvinas, Inc.	246	$263M	$1.07M	Contracting
VCEL Vericel Corporation	398	$276M	$694K	Efficient growth
XERS Xeris Biopharma Holdings, Inc.	435	$292M	$671K	Efficient growth
ADPT Adaptive Biotechnologies Corporation	624	$277M	$444K	Efficient growth
RCUS Arcus Biosciences, Inc.	601	$247M	$411K	Contracting
IOVA Iovance Biotherapeutics, Inc.	975	$264M	$270K	Efficient growth

Every Healthcare company

Questions about Arvinas, Inc.

How many employees does Arvinas, Inc. have?: Arvinas, Inc. reported 246 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 24, 2026. That is down 42.8% from a year earlier.
What is Arvinas, Inc.'s revenue per employee?: Arvinas, Inc. brought in $263M of revenue in fiscal Dec 2025, which is $1.07M per employee. That ranks 31 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare ARVN with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Arvinas, Inc.'s annual reports (Form 10-K), latest filed February 24, 2026. This is data, not a recommendation to buy or sell ARVN.